Prospective Observational Study on Heterogeneous Carcinogenesis and carbohydrate deficient transferrin (CDT) after Endoscopic Treatment of Superficial Esophageal Cancer

Prospective Observational Study on Heterogeneous Carcinogenesis and carbohydrate deficient transferrin (CDT) after Endoscopic Treatment of Superficial Esophageal Cancer - Prospective Observational Study on Heterogeneous Carcinogenesis and CDT after Endoscopic Treatment of Superficial Esophageal Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045797

Enrollment

200

Registered

2021-10-20

Start date

2021-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Between 20 and 85 years of age 2)Patients with a clinical or pathological diagnosis of superficial esophageal cancer 3)Written informed consent

Exclusion criteria

Exclusion criteria: 1)Patients with metastases 2)Patients with piecemeal resection 3)Patients with residual cancer after endoscopic treatment 4)Patients with Positive or indifinite for vertical margin 5)Patients treated with radiotherapy or systemic chemotherapy after endoscopic resection 6)Patients with previous radiotherapy or chemotherapy 7)Patients with past history of cervical Surgery or esophagectomy or gastrectomy 8)Patients with non curative cancer in other organs

Design outcomes

Primary

Measure	Time frame
The association between CDT and Heterogeneous Head, Neck, and Esophageal Cancer	—

Secondary

Measure	Time frame
1)The association between CDT and other heterogeneous carcinogenesis 2)Risk factors for heterogeneous head, neck, and esophageal cancer 3)The association between CDT and content of drinking questionnaire	—

Countries

Japan

Contacts

Public ContactMasanori Furukawa

Nara Medical University Hospital Division of Endoscopy

furukawa@naramed-u.ac.jp0744-22-3051

Outcome results